FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134779892> ?p ?o ?g. }

• W3134779892 endingPage "962" @default.
• W3134779892 startingPage "954" @default.
• W3134779892 abstract ": Proteolysis-TArgeting Chimeras (PROTACs) technology, as a strategy to chemically knock down transcription factors at the protein levels, can hijack the ubiquitin-proteasome degradation system to initiate the intracellular ubiquitin-proteasome hydrolysis process to degrade proteins. In the past, the development of drugs that target transcription factors has been greatly restricted, and even historically transcription factors have been regarded as “undruggable targets”. PROTAC technology breaks through this limitation with its unique targeting design. With several generations of technical innovation, PROTACs have become more mature and continue to make breakthroughs in the field of targeted therapy including prostate cancer (PCa), with a new strategy for the development of anti-tumor targeted drugs. PROTACs have all the advantages of existing small molecule inhibitors, are easy to administer orally, have good cell permeability, and have wider targeting profiles compared to conventional inhibitors. The disadvantage of PROTACs is the noncancer specificity, off-target and sustained-release control, due to its catalytic role. Some androgen receptor (AR) and CDK4/6 degraders have advanced the field of PCa treatment, which is being further modified given the effects of these degraders in preclinical and clinical studies. This review summarizes in detail the technological progress and challenges that have been faced with PROTACs, the progress of research on PCa, and the prospective future of PROTACs development." @default.
• W3134779892 created "2021-03-15" @default.
• W3134779892 creator A5007128432 @default.
• W3134779892 creator A5024338553 @default.
• W3134779892 creator A5044443680 @default.
• W3134779892 creator A5068301239 @default.
• W3134779892 creator A5074891719 @default.
• W3134779892 creator A5079767282 @default.
• W3134779892 date "2021-02-01" @default.
• W3134779892 modified "2023-09-27" @default.
• W3134779892 title "A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy" @default.
• W3134779892 cites W1488181101 @default.
• W3134779892 cites W1527383154 @default.
• W3134779892 cites W1565539350 @default.
• W3134779892 cites W1904433804 @default.
• W3134779892 cites W1976946414 @default.
• W3134779892 cites W1982810302 @default.
• W3134779892 cites W1986231077 @default.
• W3134779892 cites W1988013217 @default.
• W3134779892 cites W1994344724 @default.
• W3134779892 cites W2041755933 @default.
• W3134779892 cites W2051025382 @default.
• W3134779892 cites W2055568018 @default.
• W3134779892 cites W2057272791 @default.
• W3134779892 cites W2072403982 @default.
• W3134779892 cites W2089353165 @default.
• W3134779892 cites W2096170764 @default.
• W3134779892 cites W2103531329 @default.
• W3134779892 cites W2117170436 @default.
• W3134779892 cites W2121846636 @default.
• W3134779892 cites W2130189600 @default.
• W3134779892 cites W2131441324 @default.
• W3134779892 cites W2137465688 @default.
• W3134779892 cites W2148643283 @default.
• W3134779892 cites W2151683271 @default.
• W3134779892 cites W2156923287 @default.
• W3134779892 cites W2227431445 @default.
• W3134779892 cites W2292464399 @default.
• W3134779892 cites W2468923062 @default.
• W3134779892 cites W2470671857 @default.
• W3134779892 cites W2553689505 @default.
• W3134779892 cites W2589026097 @default.
• W3134779892 cites W2679430764 @default.
• W3134779892 cites W2782543572 @default.
• W3134779892 cites W2786186674 @default.
• W3134779892 cites W2788051020 @default.
• W3134779892 cites W2801402758 @default.
• W3134779892 cites W2808147451 @default.
• W3134779892 cites W2809413985 @default.
• W3134779892 cites W2810806599 @default.
• W3134779892 cites W2883077013 @default.
• W3134779892 cites W2904852935 @default.
• W3134779892 cites W2909034820 @default.
• W3134779892 cites W2923737206 @default.
• W3134779892 cites W2956397917 @default.
• W3134779892 cites W2968014120 @default.
• W3134779892 cites W2976247988 @default.
• W3134779892 cites W2978960573 @default.
• W3134779892 cites W2979943334 @default.
• W3134779892 cites W2982554531 @default.
• W3134779892 cites W2992546470 @default.
• W3134779892 cites W2999280110 @default.
• W3134779892 cites W3005962215 @default.
• W3134779892 cites W3009097360 @default.
• W3134779892 cites W3009753365 @default.
• W3134779892 cites W3041974149 @default.
• W3134779892 cites W3080167750 @default.
• W3134779892 cites W3084826602 @default.
• W3134779892 cites W3092650579 @default.
• W3134779892 doi "https://doi.org/10.21037/tau-20-1357" @default.
• W3134779892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7947434" @default.
• W3134779892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33718095" @default.
• W3134779892 hasPublicationYear "2021" @default.
• W3134779892 type Work @default.
• W3134779892 sameAs 3134779892 @default.
• W3134779892 citedByCount "5" @default.
• W3134779892 countsByYear W31347798922022 @default.
• W3134779892 countsByYear W31347798922023 @default.
• W3134779892 crossrefType "journal-article" @default.
• W3134779892 hasAuthorship W3134779892A5007128432 @default.
• W3134779892 hasAuthorship W3134779892A5024338553 @default.
• W3134779892 hasAuthorship W3134779892A5044443680 @default.
• W3134779892 hasAuthorship W3134779892A5068301239 @default.
• W3134779892 hasAuthorship W3134779892A5074891719 @default.
• W3134779892 hasAuthorship W3134779892A5079767282 @default.
• W3134779892 hasBestOaLocation W31347798921 @default.
• W3134779892 hasConcept C104317684 @default.
• W3134779892 hasConcept C121608353 @default.
• W3134779892 hasConcept C126322002 @default.
• W3134779892 hasConcept C25602115 @default.
• W3134779892 hasConcept C27740335 @default.
• W3134779892 hasConcept C2780192828 @default.
• W3134779892 hasConcept C2992195973 @default.
• W3134779892 hasConcept C502942594 @default.
• W3134779892 hasConcept C55493867 @default.
• W3134779892 hasConcept C60644358 @default.
• W3134779892 hasConcept C61367390 @default.
• W3134779892 hasConcept C70721500 @default.

• next